- Home
- BMRC vs CYRX Comparison
BMRC vs CYRX Comparison
Compare BMRC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMRC | CYRX |
|---|---|---|
| Founded | 1989 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.7M | 419.3M |
| IPO Year | 2007 | 2008 |
Fundamental Metrics
Financial Performance| Metric | BMRC | CYRX |
|---|---|---|
| Price | $26.58 | $10.07 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $28.75 | $12.94 |
| AVG Volume (30 Days) | 85.4K | ★ 404.5K |
| Earning Date | 04-27-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.75% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $394.48 | $11.06 |
| Revenue Next Year | $6.42 | $8.45 |
| P/E Ratio | ★ N/A | $7.11 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $19.69 | $5.21 |
| 52 Week High | $28.48 | $11.45 |
Technical Indicators
Market Signals| Indicator | BMRC | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 62.05 | 71.38 |
| Support Level | $26.52 | $9.18 |
| Resistance Level | $27.15 | $10.23 |
| Average True Range (ATR) | 0.53 | 0.42 |
| MACD | 0.15 | 0.18 |
| Stochastic Oscillator | 71.17 | 90.10 |
Price Performance
Historical ComparisonAbout BMRC Bank of Marin Bancorp
Bank of Marin Bancorp is a United States-based bank holding company. It conducts business through its wholly-owned subsidiary. The Bank provides a wide range of financial services to customers such as professionals, small and middle-market businesses, and individuals residing in Marin, Sonoma, Napa, San Francisco, Alameda, Contra Costa, San Mateo counties, and others. The majority of its revenue comes from interest income.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.